"","GO.cluster","IC","GO.ID","term","definition","Oral_elim.genes_frequency","Oral_elim.pvalue","Oral_elim.-log10_pvalue","Oral_elim.Significant_genes","Oral_elim.Significant_genes_symbol","Aboral_elim.genes_frequency","Aboral_elim.pvalue","Aboral_elim.-log10_pvalue","Aboral_elim.Significant_genes","Aboral_elim.Significant_genes_symbol","Cluster.name"
"1","1",8.51,"GO:0001527","microfibril","Extracellular matrix components occurring independently or along with elastin. Thought to have force-bearing functions in tendon. In addition to fibrillins, microfibrils may contain other associated proteins.","12.5% (1/8)",0.4707464,0.33,NA,NA,"37.5% (3/8)",0.002280111,2.64,"Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g28911.t1;Pocillopora_acuta_HIv2___TS.g1462.t1","Fibrillin-2 [Cleaved into: Placensin];Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide];Fibrillin-1 (MP340) [Cleaved into: Asprosin]","Cluster 1: extracellular matrix"
"2","1",8.19,"GO:0098644","complex of collagen trimers","A complex of collagen trimers such as a fibril or collagen network.","0% (0/11)",1,0,NA,NA,"63.636% (7/11)",0.003706987,2.43,"Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g23178.t1","Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XXVII) chain B","Cluster 1: extracellular matrix"
"3","1",8.51,"GO:0005584","collagen type I trimer","A collagen trimer containing alpha(I) chains. The most common form of type I collagen is a heterotrimer containing two alpha1(I) chains and one alpha2(I) chain; homotrimers containing three alpha1(I) chains are also found. Type I collagen triple helices associate to form banded fibrils.","0% (0/8)",1,0,NA,NA,"62.5% (5/8)",3.050005e-06,5.52,"Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g15832.t1","Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen)","Cluster 1: extracellular matrix"
"4","1",8.4,"GO:0090733","tenascin complex","A extracellular matrix complex involved in cell adhesion and cell migration. Typically homotrimeric or homohexameric. In mammals, four complexes exist: Tenascin-C, Tenascin-N (also known as Tenascin-W), Tenascin-X and Tenascin-R.","11.111% (1/9)",0.5112286,0.29,NA,NA,"33.333% (3/9)",0.003329147,2.48,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","Cluster 1: extracellular matrix"
"5","1",8.65,"GO:0120216","matrilin complex",NA,"28.571% (2/7)",0.09472983,1.02,NA,NA,"42.857% (3/7)",0.001464103,2.83,"Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___TS.g12453.t2","Matrilin-4 (MAT-4);Matrilin-2;Matrilin-2","Cluster 1: extracellular matrix"
"6","1",8.98,"GO:0098965","extracellular matrix of synaptic cleft","The portion of the extracellular matrix that lies within the synaptic cleft.","20% (1/5)",0.3280815,0.48,NA,NA,"60% (3/5)",0.0004416109,3.35,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C)","Cluster 1: extracellular matrix"
"7","1",7.95,"GO:0098966","perisynaptic extracellular matrix","The portion of the extracellular matrix that lies within the perisynaptic space.","16.667% (2/12)",0.2323173,0.63,NA,NA,"41.667% (5/12)",3.825561e-05,4.42,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___TS.g5115.t2","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP)","Cluster 1: extracellular matrix"
"8","1",7.95,"GO:0032579","apical lamina of hyaline layer","A fibrous network that is part of the hyalin layer extracellular matrix. The apical lamina is thought to be principally composed of the glycoproteins fibropellins. This matrix has been found in echinoderms.","42.857% (6/14)",0.0003442073,3.46,"Pocillopora_acuta_HIv2___RNAseq.g28227.t1;Pocillopora_acuta_HIv2___RNAseq.g8913.t1;Pocillopora_acuta_HIv2___RNAseq.g8915.t1;Pocillopora_acuta_HIv2___TS.g1731.t1;Pocillopora_acuta_HIv2___TS.g23115.t1;Pocillopora_acuta_HIv2___TS.g9749.t1","Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1)","7.143% (1/14)",0.4024514,0.4,NA,NA,"Cluster 1: extracellular matrix"
"9","1",5.72,"GO:0005604","basement membrane","A collagen-containing extracellular matrix consisting of a thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.","12.821% (15/117)",0.03267317,1.49,NA,NA,"20.513% (24/117)",2.893836e-12,11.54,"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g17311.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g24066.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g8258.t1","Hemicentin-1 (Fibulin-6) (FIBL-6);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Hemicentin-1 (Fibulin-6) (FIBL-6);von Willebrand factor A domain-containing protein 1;Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Hemicentin-2;Hemicentin-2;Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Papilin;Matrilin-2;Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Collagen alpha-2(IV) chain;Hemicentin-2;Hemicentin-2","Cluster 1: extracellular matrix"
"10","1",8.4,"GO:0005614","interstitial matrix","A type of extracellular matrix found in interstitial connective tissue, characterized by the presence of fibronectins, proteoglycans, and types I, III, V, VI, VII and XII collagens.","11.111% (1/9)",0.5112286,0.29,NA,NA,"44.444% (4/9)",0.0001820371,3.74,"Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___TS.g23178.t1","Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Collagen alpha-1(XXVII) chain B","Cluster 1: extracellular matrix"
"11","1",4.73,"GO:0031012","extracellular matrix","A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.","13.492% (34/252)",0.01338685,1.87,NA,NA,"21.032% (53/252)",2.565964e-06,5.59,"Pocillopora_acuta_HIv2___RNAseq.10171_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g1119.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g14375.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g1638.t1;Pocillopora_acuta_HIv2___RNAseq.g17311.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g25761.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g28911.t1;Pocillopora_acuta_HIv2___RNAseq.g30027.t1;Pocillopora_acuta_HIv2___RNAseq.g3939.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g1359.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g1462.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g24066.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g5338.t1;Pocillopora_acuta_HIv2___TS.g5618.t1;Pocillopora_acuta_HIv2___TS.g8258.t1","Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin);Hemicentin-1 (Fibulin-6) (FIBL-6);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Collagen alpha-6(VI) chain;Tissue inhibitor of metalloproteinase;Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-4(VI) chain;Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Fibrillin-2 [Cleaved into: Placensin];Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);von Willebrand factor A domain-containing protein 1;Collagen triple helix repeat-containing protein 1;Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Hemicentin-2;Hemicentin-2;Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Papilin;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Collagen alpha-6(VI) chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Protein Wnt-7a;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Matrilin-4 (MAT-4);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-2;Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide];Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4);Spondin-1 (F-spondin);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha chain;Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Fibrillin-1 (MP340) [Cleaved into: Asprosin];Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Collagen alpha-1(XXVII) chain B;Collagen alpha-2(IV) chain;Hemicentin-2;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Hemicentin-2","Cluster 1: extracellular matrix"
"12","2",7.7,"GO:0030673","axolemma","The portion of the plasma membrane surrounding an axon; it is a specialized trilaminar random mosaic of protein molecules floating within a fluid matrix of highly mobile phospholipid molecules, 7-8 nm in thickness.","33.333% (6/18)",0.001632187,2.79,"Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1","Adenosine receptor A2a;Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)","16.667% (3/18)",0.02542815,1.59,NA,NA,"Cluster 2: plasma membrane"
"13","2",6.53,"GO:0060170","ciliary membrane","The portion of the plasma membrane surrounding a cilium.","18.966% (11/58)",0.003982664,2.4,"Pocillopora_acuta_HIv2___RNAseq.g13970.t2;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g21265.t1;Pocillopora_acuta_HIv2___RNAseq.g24120.t1;Pocillopora_acuta_HIv2___RNAseq.g29617.t1;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___TS.g8275.t1","Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Septin-2;Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)","3.448% (2/58)",0.6245986,0.2,NA,NA,"Cluster 2: plasma membrane"
"14","2",5.37,"GO:0045211","postsynaptic membrane","A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane.","17.647% (30/170)",1.206467e-05,4.92,"Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.g11916.t1;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g13056.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g16.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g22296.t1;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g25228.t1;Pocillopora_acuta_HIv2___RNAseq.g26575.t1;Pocillopora_acuta_HIv2___RNAseq.g26672.t1;Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g28202.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g4399.t2;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5252.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1;Pocillopora_acuta_HIv2___RNAseq.g6094.t2;Pocillopora_acuta_HIv2___RNAseq.g8004.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g14962.t1;Pocillopora_acuta_HIv2___TS.g24662.t1;Pocillopora_acuta_HIv2___TS.g305.t1","Metabotropic glutamate receptor 3 (mGluR3);Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10);Adenosine receptor A2a;Dopamine receptor 4;Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);BTB/POZ domain-containing protein KCTD16;Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)];Neogenin;Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7);Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Neuronal acetylcholine receptor subunit beta-3;Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo);Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta);Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","5.294% (9/170)",0.1615423,0.79,NA,NA,"Cluster 2: plasma membrane"
"15","2",5.73,"GO:0042734","presynaptic membrane","A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane.","15.447% (19/123)",0.00241269,2.62,"Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g22296.t1;Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g27609.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28398.t1;Pocillopora_acuta_HIv2___RNAseq.g28466.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g3024.t4","Metabotropic glutamate receptor 3 (mGluR3);Adenosine receptor A2a;Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);BTB/POZ domain-containing protein KCTD16;Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein);Ephrin-B2a;Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Protein unc-13 homolog C (Munc13-3)","4.878% (6/123)",0.2842495,0.55,NA,NA,"Cluster 2: plasma membrane"
"16","2",4.75,"GO:0097060","synaptic membrane","A specialized area of membrane on either the presynaptic or the postsynaptic side of a synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell.","15.97% (42/263)",0.4436156,0.35,NA,NA,"6.844% (18/263)",0.006941719,2.16,"Pocillopora_acuta_HIv2___RNAseq.673_t;Pocillopora_acuta_HIv2___RNAseq.6832_t;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g16285.t1;Pocillopora_acuta_HIv2___RNAseq.g23588.t1;Pocillopora_acuta_HIv2___RNAseq.g2445.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g24030.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g8131.t1","LHFPL tetraspan subfamily member 4 protein (Lipoma HMGIC fusion partner-like 4 protein);Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B);Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Melanoma-associated antigen E1 (Alpha-dystrobrevin-associated MAGE Protein) (DAMAGE) (Hepatocellular carcinoma-associated protein 1) (MAGE-E1 antigen);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Protein turtle homolog B (Immunoglobulin superfamily member 9B);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158)","Cluster 2: plasma membrane"
"17","2",6.37,"GO:0032154","cleavage furrow","The cleavage furrow is a plasma membrane invagination at the cell division site. The cleavage furrow begins as a shallow groove and eventually deepens to divide the cytoplasm.","11.765% (8/68)",0.1458328,0.84,NA,NA,"14.706% (10/68)",0.0001487612,3.83,"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g26331.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g8258.t1","Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-2;Hemicentin-2;Septin-2;Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-2;Hemicentin-2","Cluster 2: plasma membrane"
"18","2",5.42,"GO:0009925","basal plasma membrane","The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.","13.174% (22/167)",0.008320175,2.08,"Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g12115.t1;Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g16474.t1;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g24097.t1;Pocillopora_acuta_HIv2___RNAseq.g24120.t1;Pocillopora_acuta_HIv2___RNAseq.g26594.t2;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g30992.t1;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g10198.t2;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1;Pocillopora_acuta_HIv2___TS.g1768.t1;Pocillopora_acuta_HIv2___TS.g27642.t1b","Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (NKCC1) (Na-K-CL symporter);High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]","4.79% (8/167)",0.2560215,0.59,NA,NA,"Cluster 2: plasma membrane"
"19","2",2.36,"GO:0005886","plasma membrane","The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.","9.686% (241/2488)",0.01022311,1.99,NA,NA,"5.265% (131/2488)",0.0001372503,3.86,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.673_t;Pocillopora_acuta_HIv2___RNAseq.6832_t;Pocillopora_acuta_HIv2___RNAseq.820_t;Pocillopora_acuta_HIv2___RNAseq.g10343.t1;Pocillopora_acuta_HIv2___RNAseq.g10378.t1;Pocillopora_acuta_HIv2___RNAseq.g10385.t1;Pocillopora_acuta_HIv2___RNAseq.g10557.t1;Pocillopora_acuta_HIv2___RNAseq.g10855.t1;Pocillopora_acuta_HIv2___RNAseq.g11497.t1;Pocillopora_acuta_HIv2___RNAseq.g12088.t1;Pocillopora_acuta_HIv2___RNAseq.g12258.t1;Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g14240.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14366.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g15948.t1;Pocillopora_acuta_HIv2___RNAseq.g15953.t1;Pocillopora_acuta_HIv2___RNAseq.g16285.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g16526.t1;Pocillopora_acuta_HIv2___RNAseq.g17416.t1;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g18385.t1;Pocillopora_acuta_HIv2___RNAseq.g18425.t1;Pocillopora_acuta_HIv2___RNAseq.g20576.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g21032.t1;Pocillopora_acuta_HIv2___RNAseq.g21518.t1;Pocillopora_acuta_HIv2___RNAseq.g21588.t1a;Pocillopora_acuta_HIv2___RNAseq.g22691.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g23588.t1;Pocillopora_acuta_HIv2___RNAseq.g24040.t1;Pocillopora_acuta_HIv2___RNAseq.g24196.t1;Pocillopora_acuta_HIv2___RNAseq.g24413.t1;Pocillopora_acuta_HIv2___RNAseq.g2445.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g25184.t1;Pocillopora_acuta_HIv2___RNAseq.g25186.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g25885.t1;Pocillopora_acuta_HIv2___RNAseq.g26057.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g26319.t1;Pocillopora_acuta_HIv2___RNAseq.g26331.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g27031.t1;Pocillopora_acuta_HIv2___RNAseq.g27566.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28252.t1;Pocillopora_acuta_HIv2___RNAseq.g28575.t1a;Pocillopora_acuta_HIv2___RNAseq.g28577.t1;Pocillopora_acuta_HIv2___RNAseq.g28818.t1;Pocillopora_acuta_HIv2___RNAseq.g2884.t1;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g29446.t1;Pocillopora_acuta_HIv2___RNAseq.g29795.t1;Pocillopora_acuta_HIv2___RNAseq.g30377.t2;Pocillopora_acuta_HIv2___RNAseq.g30593.t1;Pocillopora_acuta_HIv2___RNAseq.g30657.t1;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g3094.t1;Pocillopora_acuta_HIv2___RNAseq.g30954.t1;Pocillopora_acuta_HIv2___RNAseq.g3515.t1;Pocillopora_acuta_HIv2___RNAseq.g4073.t1;Pocillopora_acuta_HIv2___RNAseq.g434.t1;Pocillopora_acuta_HIv2___RNAseq.g4679.t1;Pocillopora_acuta_HIv2___RNAseq.g4878.t1;Pocillopora_acuta_HIv2___RNAseq.g5145.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g5871.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g775.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g802.t1;Pocillopora_acuta_HIv2___RNAseq.g805.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g829.t1;Pocillopora_acuta_HIv2___RNAseq.g8670.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___RNAseq.g9049.t1;Pocillopora_acuta_HIv2___RNAseq.g9054.t1;Pocillopora_acuta_HIv2___RNAseq.g9056.t1;Pocillopora_acuta_HIv2___RNAseq.g9098.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1;Pocillopora_acuta_HIv2___RNAseq.g9839.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12121.t1;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g12848.t1;Pocillopora_acuta_HIv2___TS.g15585.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g186.t2;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g23673.t1;Pocillopora_acuta_HIv2___TS.g24030.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g24890.t1;Pocillopora_acuta_HIv2___TS.g25584.t1;Pocillopora_acuta_HIv2___TS.g28528.t1b;Pocillopora_acuta_HIv2___TS.g29372.t2;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g4840.t1;Pocillopora_acuta_HIv2___TS.g5006.t1b;Pocillopora_acuta_HIv2___TS.g5308.t2;Pocillopora_acuta_HIv2___TS.g7543.t1;Pocillopora_acuta_HIv2___TS.g8131.t1;Pocillopora_acuta_HIv2___TS.g8258.t1;Pocillopora_acuta_HIv2___TS.g8259.t1b","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Hemicentin-1 (Fibulin-6) (FIBL-6);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);LHFPL tetraspan subfamily member 4 protein (Lipoma HMGIC fusion partner-like 4 protein);Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B);Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase);Protocadherin Fat 3 (FAT tumor suppressor homolog 3);Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206);Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5);Fibroblast growth factor receptor-like 1;Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R);Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor);Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Chick receptor tyrosine phosphatase alpha) (CRYP alpha) (CRYPalpha);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1) (Vanin-1);Hemicentin-1 (Fibulin-6) (FIBL-6);Scavenger receptor class A member 5;Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1);Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Cell wall protein DAN4 (Delayed anaerobic protein 4);Glypican-5 [Cleaved into: Secreted glypican-5];Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains);Patched domain-containing protein 3 (RND-type protein RNDEu-3);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B);Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase);Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25);Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107);Hemicentin-2;Hemicentin-2;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Synaptotagmin-3 (Synaptotagmin III) (SytIII);Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R);Toll-like receptor 2 (CD antigen CD282);Melanoma-associated antigen E1 (Alpha-dystrobrevin-associated MAGE Protein) (DAMAGE) (Hepatocellular carcinoma-associated protein 1) (MAGE-E1 antigen);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);TNF receptor-associated factor 5;TNF receptor-associated factor 5;Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-);Septin-2;Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2);Hephaestin-like protein (EC 1.-.-.-);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2);Synaptotagmin-10 (Synaptotagmin X) (SytX);Aquaporin-3 (Aquaglyceroporin-3);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Roundabout homolog 2;Phosphatidylinositol-3-phosphate phosphatase MTMR1 (EC 3.1.3.-) (Myotubularin-related protein 1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95);Zonadhesin;Rhodopsin, GQ-coupled (GQ-rhodopsin);Ras-related protein Rab-8B (EC 3.6.5.2);Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2);Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Melatonin receptor type 1C (Mel-1C-R) (Mel1c receptor) (CKB);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R);Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);Frizzled-5 (Fz-5) (Xfz5);Ras-related protein Rab-38 (EC 3.6.5.2) (Melanoma antigen NY-MEL-1);Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228);Serine/threonine-protein kinase H1 (EC 2.7.11.1) (Protein serine kinase H1) (PSK-H1);Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Hemicentin-1 (Fibulin-6) (FIBL-6);Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Membrane-spanning 4-domains subfamily A member 4A (CD20 antigen-like 1) (Four-span transmembrane protein 1);Roundabout homolog 1;Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor);Protein jagged-1 (Jagged1) (CD antigen CD339);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Protein turtle homolog B (Immunoglobulin superfamily member 9B);Hemicentin-1 (Fibulin-6) (FIBL-6);Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (Potassium channel, inwardly rectifying subfamily J member 2);Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1);Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76);CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein REDUCED CHLOROPLAST COVERAGE 2 (Protein TPR-domain suppressor of STIMPY);Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Scavenger receptor class A member 5;Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK);Hemicentin-1 (Fibulin-6) (FIBL-6);Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12);Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Signal peptide, CUB and EGF-like domain-containing protein 3;Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2) (Neural cell adhesion molecule RB-8) (R4B12);Hemicentin-2;BTB/POZ domain-containing protein KCTD7;CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3);Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Tyrosine kinase receptor CEK2);Trimethylamine transporter (TMA transporter) (TMA-specific transporter);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Proton-coupled folate transporter (Solute carrier family 46 member 1);Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains);Metabotropic glycine receptor (mGlyR) (G-protein coupled receptor 158);Hemicentin-2;Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1)","Cluster 2: plasma membrane"
"20","3",6.66,"GO:0032420","stereocilium","An actin-based protrusion from the apical surface of auditory and vestibular hair cells and of neuromast cells. These protrusions are supported by a bundle of cross-linked actin filaments (an actin cable), oriented such that the plus (barbed) ends are at the tip of the protrusion, capped by a tip complex which bridges to the plasma. Bundles of stereocilia act as mechanosensory organelles.","24.39% (10/41)",0.0008129884,3.09,"Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g20846.t1;Pocillopora_acuta_HIv2___RNAseq.g25708.t1;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___TS.g10198.t2;Pocillopora_acuta_HIv2___TS.g14552.t1;Pocillopora_acuta_HIv2___TS.g4109.t3","Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);Lipoxygenase homology domain-containing protein 1;Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q);Cadherin-23 (Otocadherin);Pejvakin (Autosomal recessive deafness type 59 protein)","0% (0/41)",1,0,NA,NA,"Cluster 3: plasma membrane bounded cell projection"
"21","3",7.41,"GO:0097386","glial cell projection","A prolongation or process extending from a glial cell.","25% (6/24)",0.007976828,2.1,"Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g30425.t2;Pocillopora_acuta_HIv2___RNAseq.g4770.t1;Pocillopora_acuta_HIv2___TS.g201.t2","Metabotropic glutamate receptor 3 (mGluR3);Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Rootletin (Ciliary rootlet coiled-coil protein);Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)","4.167% (1/24)",0.5865276,0.23,NA,NA,"Cluster 3: plasma membrane bounded cell projection"
"22","3",6.03,"GO:0044306","neuron projection terminus","The specialized, terminal region of a neuron projection such as an axon or a dendrite.","15.663% (13/83)",0.009862255,2.01,"Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g7550.t1;Pocillopora_acuta_HIv2___TS.g26333.t1;Pocillopora_acuta_HIv2___TS.g28908.t1;Pocillopora_acuta_HIv2___TS.g3024.t4;Pocillopora_acuta_HIv2___TS.g9513.t1","Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);MOB kinase activator 2 (Mob2 homolog) (Mps one binder kinase activator-like 2) (Ovary-specific MOB-like protein);Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1);Complexin-1;Protein unc-13 homolog C (Munc13-3);Carcinine transporter","1.205% (1/83)",0.9532717,0.02,NA,NA,"Cluster 3: plasma membrane bounded cell projection"
"23","3",4.31,"GO:0030424","axon","The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.","12.113% (47/388)",0.009008225,2.05,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g12682.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g24649.t1;Pocillopora_acuta_HIv2___RNAseq.g26575.t1;Pocillopora_acuta_HIv2___RNAseq.g26596.t1;Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g27609.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28408.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g299.t1;Pocillopora_acuta_HIv2___RNAseq.g3840.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c;Pocillopora_acuta_HIv2___RNAseq.g4399.t2;Pocillopora_acuta_HIv2___RNAseq.g5252.t1;Pocillopora_acuta_HIv2___RNAseq.g5711.t2;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1;Pocillopora_acuta_HIv2___RNAseq.g8004.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___TS.g1768.t1;Pocillopora_acuta_HIv2___TS.g21128.t1;Pocillopora_acuta_HIv2___TS.g22704.t2;Pocillopora_acuta_HIv2___TS.g24662.t1;Pocillopora_acuta_HIv2___TS.g25792.t1c;Pocillopora_acuta_HIv2___TS.g26333.t1;Pocillopora_acuta_HIv2___TS.g28908.t1;Pocillopora_acuta_HIv2___TS.g3024.t4;Pocillopora_acuta_HIv2___TS.g800.t1;Pocillopora_acuta_HIv2___TS.g9513.t1","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Metabotropic glutamate receptor 3 (mGluR3);Adenosine receptor A2a;Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Sacsin (DnaJ homolog subfamily C member 29);Neogenin;Hemicentin-2;Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adaptor-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a);Synaptotagmin-1 (Synaptotagmin I) (SytI);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Sacsin (DnaJ homolog subfamily C member 29);Advillin (p92);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2);Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17);WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b);Calmodulin-like protein 3;Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related);Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1);Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1);Complexin-1;Protein unc-13 homolog C (Munc13-3);Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C);Carcinine transporter","3.093% (12/388)",0.7497649,0.13,NA,NA,"Cluster 3: plasma membrane bounded cell projection"
"24","4",6.42,"GO:0098685","Schaffer collateral - CA1 synapse","A synapse between the Schaffer collateral axon of a CA3 pyramidal cell and a CA1 pyramidal cell.","6.154% (4/65)",0.7424168,0.13,NA,NA,"13.846% (9/65)",0.0005032783,3.3,"Pocillopora_acuta_HIv2___RNAseq.g12272.t1;Pocillopora_acuta_HIv2___RNAseq.g12278.t1;Pocillopora_acuta_HIv2___RNAseq.g16928.t3;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g9253.t1;Pocillopora_acuta_HIv2___TS.g30914.t1;Pocillopora_acuta_HIv2___TS.g3265.t1;Pocillopora_acuta_HIv2___TS.g4983.t1","Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28);Regulator of G-protein signaling 19 (RGS19) (G-alpha-interacting protein) (GAIP);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Protein Wnt-7a;Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48);F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like)","Cluster 4: cell junction"
"25","4",7.6,"GO:0005927","muscle tendon junction","A cell-substrate junction found at the terminal anchorage site of skeletal muscle cells to tendons.","20% (4/20)",0.06143236,1.21,NA,NA,"25% (5/20)",0.000589738,3.23,"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g15590.t1","Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6)","Cluster 4: cell junction"
"26","4",8.29,"GO:0033010","paranodal junction","A highly specialized cell-cell junction found in vertebrates, which forms between a neuron and a glial cell, and has structural similarity to Drosophila septate junctions. It flanks the node of Ranvier in myelinated nerve and electrically isolates the myelinated from unmyelinated nerve segments and physically separates the voltage-gated sodium channels at the node from the cluster of potassium channels underneath the myelin sheath.","40% (4/10)",0.00489397,2.31,"Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___TS.g18947.t1","Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)","0% (0/10)",1,0,NA,NA,"Cluster 4: cell junction"
"27","4",6.13,"GO:0005912","adherens junction","A cell-cell junction composed of the epithelial cadherin-catenin complex. The epithelial cadherins, or E-cadherins, of each interacting cell extend through the plasma membrane into the extracellular space and bind to each other. The E-cadherins bind to catenins on the cytoplasmic side of the membrane, where the E-cadherin-catenin complex binds to cytoskeletal components and regulatory and signaling molecules.","10.345% (9/87)",0.2189169,0.66,NA,NA,"11.494% (10/87)",0.001115739,2.95,"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g25739.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g6576.t2","Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-1 (Fibulin-6) (FIBL-6);Ephrin-B2 (ELF-2) (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Hemicentin-1 (Fibulin-6) (FIBL-6);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Hemicentin-1 (Fibulin-6) (FIBL-6);LIM domain-containing protein jub","Cluster 4: cell junction"
"28","5",4.83,"GO:0070062","extracellular exosome","A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.","6.897% (22/319)",0.7254194,0.14,NA,NA,"6.583% (21/319)",0.005758438,2.24,"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.g11877.t2b;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12745.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g13818.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___RNAseq.g9098.t1;Pocillopora_acuta_HIv2___TS.g11111.t2;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g5618.t1","Hemicentin-1 (Fibulin-6) (FIBL-6);Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2];Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13);Hemicentin-1 (Fibulin-6) (FIBL-6);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Roundabout homolog 2;Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Roundabout homolog 2;Hemicentin-1 (Fibulin-6) (FIBL-6);Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)];Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain];Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1);Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","Cluster 5: cellular anatomical structure"
"29","5",3.27,"GO:0005576","extracellular region","The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.","10.364% (128/1235)",0.0001339397,3.87,"Pocillopora_acuta_HIv2___RNAseq.22067_t;Pocillopora_acuta_HIv2___RNAseq.6093_tb;Pocillopora_acuta_HIv2___RNAseq.6257_t;Pocillopora_acuta_HIv2___RNAseq.g10475.t1;Pocillopora_acuta_HIv2___RNAseq.g10991.t1;Pocillopora_acuta_HIv2___RNAseq.g11410.t1;Pocillopora_acuta_HIv2___RNAseq.g11580.t1;Pocillopora_acuta_HIv2___RNAseq.g12.t1;Pocillopora_acuta_HIv2___RNAseq.g12215.t1;Pocillopora_acuta_HIv2___RNAseq.g12286.t1;Pocillopora_acuta_HIv2___RNAseq.g12290.t1;Pocillopora_acuta_HIv2___RNAseq.g12292.t1;Pocillopora_acuta_HIv2___RNAseq.g12752.t1;Pocillopora_acuta_HIv2___RNAseq.g13.t1;Pocillopora_acuta_HIv2___RNAseq.g13044.t1;Pocillopora_acuta_HIv2___RNAseq.g13338.t1;Pocillopora_acuta_HIv2___RNAseq.g13339.t1;Pocillopora_acuta_HIv2___RNAseq.g13576.t1;Pocillopora_acuta_HIv2___RNAseq.g14330.t3;Pocillopora_acuta_HIv2___RNAseq.g14336.t1;Pocillopora_acuta_HIv2___RNAseq.g14337.t1;Pocillopora_acuta_HIv2___RNAseq.g14348.t1;Pocillopora_acuta_HIv2___RNAseq.g14640.t1;Pocillopora_acuta_HIv2___RNAseq.g15036.t2;Pocillopora_acuta_HIv2___RNAseq.g1508.t1;Pocillopora_acuta_HIv2___RNAseq.g1510.t1;Pocillopora_acuta_HIv2___RNAseq.g15370.t1;Pocillopora_acuta_HIv2___RNAseq.g15574.t1;Pocillopora_acuta_HIv2___RNAseq.g15577.t1;Pocillopora_acuta_HIv2___RNAseq.g15584.t1;Pocillopora_acuta_HIv2___RNAseq.g15838.t1;Pocillopora_acuta_HIv2___RNAseq.g16095.t1;Pocillopora_acuta_HIv2___RNAseq.g16699.t1;Pocillopora_acuta_HIv2___RNAseq.g17085.t1;Pocillopora_acuta_HIv2___RNAseq.g17089.t1;Pocillopora_acuta_HIv2___RNAseq.g17090.t1;Pocillopora_acuta_HIv2___RNAseq.g18123.t1;Pocillopora_acuta_HIv2___RNAseq.g18214.t1;Pocillopora_acuta_HIv2___RNAseq.g19312.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g20232.t1;Pocillopora_acuta_HIv2___RNAseq.g20413.t2;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g20712.t1;Pocillopora_acuta_HIv2___RNAseq.g20860.t1;Pocillopora_acuta_HIv2___RNAseq.g21476.t1;Pocillopora_acuta_HIv2___RNAseq.g21627.t1;Pocillopora_acuta_HIv2___RNAseq.g21637.t1;Pocillopora_acuta_HIv2___RNAseq.g2185.t1b;Pocillopora_acuta_HIv2___RNAseq.g21957.t1;Pocillopora_acuta_HIv2___RNAseq.g22283.t1;Pocillopora_acuta_HIv2___RNAseq.g2258.t1;Pocillopora_acuta_HIv2___RNAseq.g23049.t1;Pocillopora_acuta_HIv2___RNAseq.g23757.t1;Pocillopora_acuta_HIv2___RNAseq.g24120.t1;Pocillopora_acuta_HIv2___RNAseq.g25458.t1;Pocillopora_acuta_HIv2___RNAseq.g25934.t1;Pocillopora_acuta_HIv2___RNAseq.g26596.t1;Pocillopora_acuta_HIv2___RNAseq.g26608.t1;Pocillopora_acuta_HIv2___RNAseq.g26701.t1;Pocillopora_acuta_HIv2___RNAseq.g26782.t1;Pocillopora_acuta_HIv2___RNAseq.g26783.t1;Pocillopora_acuta_HIv2___RNAseq.g27399.t1;Pocillopora_acuta_HIv2___RNAseq.g28025.t1;Pocillopora_acuta_HIv2___RNAseq.g28227.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28678.t1;Pocillopora_acuta_HIv2___RNAseq.g28742.t1;Pocillopora_acuta_HIv2___RNAseq.g28858.t1;Pocillopora_acuta_HIv2___RNAseq.g29115.t1;Pocillopora_acuta_HIv2___RNAseq.g29841.t1;Pocillopora_acuta_HIv2___RNAseq.g29984.t1;Pocillopora_acuta_HIv2___RNAseq.g30230.t1;Pocillopora_acuta_HIv2___RNAseq.g30425.t2;Pocillopora_acuta_HIv2___RNAseq.g31286.t1c;Pocillopora_acuta_HIv2___RNAseq.g3222.t1;Pocillopora_acuta_HIv2___RNAseq.g3624.t1;Pocillopora_acuta_HIv2___RNAseq.g3724.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4399.t2;Pocillopora_acuta_HIv2___RNAseq.g4770.t1;Pocillopora_acuta_HIv2___RNAseq.g4879.t1;Pocillopora_acuta_HIv2___RNAseq.g4954.t1;Pocillopora_acuta_HIv2___RNAseq.g584.t3a;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g687.t1;Pocillopora_acuta_HIv2___RNAseq.g7107.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___RNAseq.g7443.t1;Pocillopora_acuta_HIv2___RNAseq.g7553.t1;Pocillopora_acuta_HIv2___RNAseq.g7667.t1;Pocillopora_acuta_HIv2___RNAseq.g7692.t1;Pocillopora_acuta_HIv2___RNAseq.g8217.t1;Pocillopora_acuta_HIv2___RNAseq.g8520.t1;Pocillopora_acuta_HIv2___RNAseq.g8913.t1;Pocillopora_acuta_HIv2___RNAseq.g8915.t1;Pocillopora_acuta_HIv2___RNAseq.g9027.t1;Pocillopora_acuta_HIv2___RNAseq.g9631.t1;Pocillopora_acuta_HIv2___RNAseq.g993.t1;Pocillopora_acuta_HIv2___RNAseq.g994.t1;Pocillopora_acuta_HIv2___TS.g13342.t1;Pocillopora_acuta_HIv2___TS.g1731.t1;Pocillopora_acuta_HIv2___TS.g19499.t2;Pocillopora_acuta_HIv2___TS.g19790.t1;Pocillopora_acuta_HIv2___TS.g20007.t1;Pocillopora_acuta_HIv2___TS.g201.t2;Pocillopora_acuta_HIv2___TS.g20880.t1;Pocillopora_acuta_HIv2___TS.g21857.t1;Pocillopora_acuta_HIv2___TS.g23115.t1;Pocillopora_acuta_HIv2___TS.g23175.t1;Pocillopora_acuta_HIv2___TS.g24662.t1;Pocillopora_acuta_HIv2___TS.g24807.t1;Pocillopora_acuta_HIv2___TS.g25792.t1c;Pocillopora_acuta_HIv2___TS.g27642.t1b;Pocillopora_acuta_HIv2___TS.g29407.t1;Pocillopora_acuta_HIv2___TS.g29618.t1;Pocillopora_acuta_HIv2___TS.g29621.t1;Pocillopora_acuta_HIv2___TS.g3256.t1;Pocillopora_acuta_HIv2___TS.g4148.t1c;Pocillopora_acuta_HIv2___TS.g5148.t1;Pocillopora_acuta_HIv2___TS.g8089.t1;Pocillopora_acuta_HIv2___TS.g8275.t1;Pocillopora_acuta_HIv2___TS.g9414.t1;Pocillopora_acuta_HIv2___TS.g9749.t1;Pocillopora_acuta_HIv2___TS.g9752.t3;Pocillopora_acuta_HIv2___TS.g9777.t1","Protein Wnt-2b;Multiple coagulation factor deficiency protein 2 homolog (Neural stem cell-derived neuronal survival protein);Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Myoferlin (Fer-1-like protein 3);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Sperm-associated antigen 17 (Projection protein PF6 homolog);Hemicentin-1 (Fibulin-6) (FIBL-6);Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican);Thioredoxin (Trx);Fucolectin-4;Fucolectin;Fucolectin;A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-);Immunoglobulin superfamily member 10 (IgSF10);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Perlucin-like protein;Perlucin-like protein;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);CUB and peptidase domain-containing protein 1;CUB and peptidase domain-containing protein 1;CUB and peptidase domain-containing protein 1;Collagen alpha-4(VI) chain;Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein);Collagen alpha-1(XXIV) chain;Tachylectin-2 (Lectin L10c);Tachylectin-2 (Lectin L10c);Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)];Creatine kinase, testis isozyme (EC 2.7.3.2);Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK);Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK);Laminin subunit gamma-1;BPTI/Kunitz domain-containing protein;Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Peroxidasin homolog pxn-2 (EC 1.11.2.-);Peroxidasin homolog pxn-2 (EC 1.11.2.-);Peroxidasin homolog pxn-2 (EC 1.11.2.-);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1);Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-);Hemagglutinin/amebocyte aggregation factor (18K-LAF);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Cilia- and flagella-associated protein 54;Reversion-inducing cysteine-rich protein with Kazal motifs;Putative gastrointestinal growth factor xP4 (TFF p4.1);DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X);CD63 antigen (CD antigen CD63);Arginine kinase (AK) (EC 2.7.3.3);Hydramacin-1 (Hm-1);tRNA(Glu)-specific nuclease WapA (EC 3.1.-.-) (Cell wall-associated protein) (RNase WapA) (Toxin WapA);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];UPF0764 protein C16orf89 homolog;Fibrillin-1 [Cleaved into: Asprosin];Hemicentin-2;Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1);Accumulation-associated protein;Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid);Protein mesh;Tolloid-like protein 2 (EC 3.4.24.-) (Metalloprotease xolloid) (Xenopus tolloid);Cubilin (Intrinsic factor-cobalamin receptor);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A);LWamide neuropeptides [Cleaved into: LWamide I; LWamide II; LWS];Collectin-11 (Collectin kidney protein 1) (CL-K1);Collagen alpha-3(VI) chain;Matrilin-2;Protein Wnt-2b-A (Wnt-2b) (XWnt-2b) (XWnt-2);Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14);Rootletin (Ciliary rootlet coiled-coil protein);Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5);Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III);Hatching enzyme 1.2 (EC 3.4.24.67) (Choriolysin H homolog 1) (High choriolytic enzyme 1 homolog) (zHCE-1);Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2);Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);Serotransferrin;Glucose-fructose oxidoreductase domain-containing protein 1 (Gfo/Idh/MocA-like oxidoreductase domain-containing protein 1);von Willebrand factor (vWF);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase);Insulin-like growth factor-binding protein complex acid labile subunit (ALS);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Glutamine amidotransferase-like class 1 domain-containing protein 1 (Ferry endosomal RAB5 effector complex subunit 5) (Fy-5) (Parkinson disease 7 domain-containing protein 1);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form];Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog);Netrin-1;LWamide neuropeptides [Cleaved into: LWamide I; Metamorphosin A (MMA) (LWamide II); LWamide III; LWamide IV; LWamide V; LWamide VI; LWamide VII; LWamide VIII; LWamide IX];Hemicentin-1 (Fibulin-6) (FIBL-6);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Bone morphogenetic protein 6 (BMP-6) (VG-1-related protein) (VG-1-R) (VGR-1);Repetitive proline-rich cell wall protein 2;Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34);Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34);Nephrocystin-3;Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-3 (Epidermal growth factor-related protein 3) (Fibropellin III) (Fibropellin-c) (SpEGF III);Chloride intracellular channel protein 3 (Glutaredoxin-like oxidoreductase CLIC3) (EC 1.8.-.-);Thrombospondin-3;Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5);Cell growth regulator with EF hand domain protein 1 (Cell growth regulatory gene 11 protein) (Hydrophobestin);Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Hemicentin-1 (Fibulin-6) (FIBL-6);Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related);Hemicentin-1 (Fibulin-6) (FIBL-6);Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1);Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1];Matrilin-2;Low-density lipoprotein receptor-related protein 6 (LRP-6);Low-density lipoprotein receptor-related protein 6 (LRP-6);Fucolectin-3;Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM);6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44);Endo-1,4-beta-xylanase B (Xylanase B) (EC 3.2.1.8) (1,4-beta-D-xylan xylanohydrolase B);Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI);Follistatin-related protein 5 (Follistatin-like protein 5) (m-D/Bsp120I 1-2);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form];Oncoprotein-induced transcript 3 protein","12.874% (159/1235)",1.459036e-26,25.84,"Pocillopora_acuta_HIv2___RNAseq.10171_t;Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.21012_t;Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g1119.t1;Pocillopora_acuta_HIv2___RNAseq.g1127.t2;Pocillopora_acuta_HIv2___RNAseq.g11877.t2b;Pocillopora_acuta_HIv2___RNAseq.g12045.t1;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12372.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12376.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g1273.t1;Pocillopora_acuta_HIv2___RNAseq.g12745.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g13818.t1;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14257.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g14375.t1;Pocillopora_acuta_HIv2___RNAseq.g14769.t1;Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g15172.t1;Pocillopora_acuta_HIv2___RNAseq.g15279.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g15832.t1;Pocillopora_acuta_HIv2___RNAseq.g1638.t1;Pocillopora_acuta_HIv2___RNAseq.g16526.t1;Pocillopora_acuta_HIv2___RNAseq.g17311.t1;Pocillopora_acuta_HIv2___RNAseq.g17416.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g19085.t1;Pocillopora_acuta_HIv2___RNAseq.g19470.t1;Pocillopora_acuta_HIv2___RNAseq.g1970.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g20576.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g21518.t1;Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g22262.t1;Pocillopora_acuta_HIv2___RNAseq.g22527.t1;Pocillopora_acuta_HIv2___RNAseq.g22559.t1;Pocillopora_acuta_HIv2___RNAseq.g22572.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g23898.t1;Pocillopora_acuta_HIv2___RNAseq.g24766.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g24899.t1;Pocillopora_acuta_HIv2___RNAseq.g25208.t1;Pocillopora_acuta_HIv2___RNAseq.g25270.t1;Pocillopora_acuta_HIv2___RNAseq.g25274.t1;Pocillopora_acuta_HIv2___RNAseq.g25351.t1;Pocillopora_acuta_HIv2___RNAseq.g2565.t1;Pocillopora_acuta_HIv2___RNAseq.g25761.t1;Pocillopora_acuta_HIv2___RNAseq.g25890.t1;Pocillopora_acuta_HIv2___RNAseq.g25935.t1;Pocillopora_acuta_HIv2___RNAseq.g26035.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g26319.t1;Pocillopora_acuta_HIv2___RNAseq.g26589.t1;Pocillopora_acuta_HIv2___RNAseq.g26590.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28109.t1;Pocillopora_acuta_HIv2___RNAseq.g28195.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28450.t1;Pocillopora_acuta_HIv2___RNAseq.g28504.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28800.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g28910.t1;Pocillopora_acuta_HIv2___RNAseq.g28911.t1;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g30027.t1;Pocillopora_acuta_HIv2___RNAseq.g30215.t1;Pocillopora_acuta_HIv2___RNAseq.g30235.t1;Pocillopora_acuta_HIv2___RNAseq.g30304.t2;Pocillopora_acuta_HIv2___RNAseq.g30322.t1;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g30954.t1;Pocillopora_acuta_HIv2___RNAseq.g31081.t1;Pocillopora_acuta_HIv2___RNAseq.g31347.t1;Pocillopora_acuta_HIv2___RNAseq.g3780.t1;Pocillopora_acuta_HIv2___RNAseq.g3826.t1;Pocillopora_acuta_HIv2___RNAseq.g39.t2;Pocillopora_acuta_HIv2___RNAseq.g3939.t1;Pocillopora_acuta_HIv2___RNAseq.g4202.t1;Pocillopora_acuta_HIv2___RNAseq.g4746.t1;Pocillopora_acuta_HIv2___RNAseq.g4785.t1;Pocillopora_acuta_HIv2___RNAseq.g4791.t1;Pocillopora_acuta_HIv2___RNAseq.g4878.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g5347.t1;Pocillopora_acuta_HIv2___RNAseq.g5348.t1a;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g715.t1;Pocillopora_acuta_HIv2___RNAseq.g7635.t1;Pocillopora_acuta_HIv2___RNAseq.g8098.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g8587.t1;Pocillopora_acuta_HIv2___RNAseq.g8820.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8922.t1;Pocillopora_acuta_HIv2___RNAseq.g9068.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___RNAseq.g9098.t1;Pocillopora_acuta_HIv2___RNAseq.g9118.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1;Pocillopora_acuta_HIv2___RNAseq.g9756.t1;Pocillopora_acuta_HIv2___TS.g10825.t1;Pocillopora_acuta_HIv2___TS.g11111.t2;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g12320.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g12860.t1;Pocillopora_acuta_HIv2___TS.g1340.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g1359.t1;Pocillopora_acuta_HIv2___TS.g13882.t1c;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g1462.t1;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g15792.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g23133.t3;Pocillopora_acuta_HIv2___TS.g23144.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g23673.t1;Pocillopora_acuta_HIv2___TS.g24066.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g26127.t2b;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g5338.t1;Pocillopora_acuta_HIv2___TS.g5618.t1;Pocillopora_acuta_HIv2___TS.g8258.t1","Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Hensin);Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Hemicentin-1 (Fibulin-6) (FIBL-6);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Collagen alpha-6(VI) chain;Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein);Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2];Somatomedin-B and thrombospondin type-1 domain-containing protein (RPE-spondin);Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Tissue inhibitor of metalloproteinase;Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);von Willebrand factor D and EGF domain-containing protein;Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13);Bone morphogenetic protein 2 (BMP-2);Hemicentin-1 (Fibulin-6) (FIBL-6);NPC intracellular cholesterol transporter 2 (EPI-1) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog);Collagen alpha-4(VI) chain;Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Fibrillin-2 [Cleaved into: Placensin];Noggin-2;Insoluble matrix shell protein 1 (IMSP1);Apolipoprotein L3 (Apolipoprotein L-III) (ApoL-III) (TNF-inducible protein CG12-1) (CG12_1);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Cell wall protein DAN4 (Delayed anaerobic protein 4);von Willebrand factor A domain-containing protein 1;Glypican-5 [Cleaved into: Secreted glypican-5];Collagen triple helix repeat-containing protein 1;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Halomucin;Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP);Skeletal aspartic acid-rich protein 1;Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase);Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain];Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid);Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Hemicentin-2;Hemicentin-2;Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);von Willebrand factor A domain-containing protein 7 (Protein G7c);Papilin;Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP);Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form);Mammalian ependymin-related protein 1 (MERP-1);Secreted frizzled-related protein 5 (sFRP-5);Collagen alpha-6(VI) chain;MAM and LDL-receptor class A domain-containing protein 1 (Skeletal organic matrix MAM and LDL-receptor 1) (SOM MAM and LDL-receptor 1);MAM and LDL-receptor class A domain-containing protein 2 (Skeletal organic matrix MAM and LDL-receptor 2) (SOM MAM and LDL-receptor 2);Threonine-rich protein;Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-);Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2);Tear acid lipase-like protein (TALLP);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Protein Wnt-7a;Protein Wnt-8b;Protein Wnt-8a;Fibulin-2 (FIBL-2);Serine protease inhibitor dipetalogastin (Dipetalin);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Trypsin-3 (EC 3.4.21.4) (Trypsin III);Matrilin-4 (MAT-4);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-3;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Matrilin-2;Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide];Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Roundabout homolog 2;Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4);Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain];Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15);Galaxin;Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form];Equistatin (EI) (Cysteine proteinase inhibitor);Protein kinase C-binding protein NELL1 (NEL-like protein 1);Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2);Kielin/chordin-like protein (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin);Spondin-1 (F-spondin);Apolipophorins [Cleaved into: Apolipophorin-2 (Apolipophorin II) (apoLp-2); Apolipophorin-1 (Apolipophorin I) (apoLp-1)];Class II hydrophobin C;Coagulation factor VIII (Procoagulant component);Coagulation factor VIII (Procoagulant component);Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228);Roundabout homolog 2;Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30);Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30);Hemicentin-1 (Fibulin-6) (FIBL-6);von Willebrand factor A domain-containing protein 7 (Protein G7c);Small cysteine-rich protein 1 (Amil-SCRiP1) (SCRiP1);Cathepsin L1 (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain];Hemicentin-1 (Fibulin-6) (FIBL-6);Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14);Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)];Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b (Complement C3b-alpha' chain); Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3b (Complement C3b-alpha' chain)];Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: Complement factor B Ba; Complement factor B Bb];Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)];Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain];Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx);Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module);Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1);Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Alpha-crystallin B chain (Alpha(B)-crystallin);Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-1(VI) chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha chain;Zinc metalloproteinase nas-13 (EC 3.4.24.-) (Nematode astacin 13);Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Fibrillin-1 (MP340) [Cleaved into: Asprosin];Hemicentin-1 (Fibulin-6) (FIBL-6);Acidic skeletal organic matrix protein (Acidic SOMP);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3b (Complement C3b-alpha' chain)];Collagen alpha-1(XXVII) chain B;Signal peptide, CUB and EGF-like domain-containing protein 3;Collagen alpha-2(IV) chain;Hemicentin-2;Adhesive plaque matrix protein (Foot protein 1) (MGFP-1) (MGFP1);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Hemicentin-2","Cluster 5: cellular anatomical structure"
"30","5",3.93,"GO:0005615","extracellular space","That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.","8.853% (61/689)",0.1231987,0.91,NA,NA,"13.062% (90/689)",7.058214e-32,31.15,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.21012_t;Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.7335_t;Pocillopora_acuta_HIv2___RNAseq.g1075.t1;Pocillopora_acuta_HIv2___RNAseq.g1127.t2;Pocillopora_acuta_HIv2___RNAseq.g11877.t2b;Pocillopora_acuta_HIv2___RNAseq.g12281.t1;Pocillopora_acuta_HIv2___RNAseq.g12372.t1;Pocillopora_acuta_HIv2___RNAseq.g12374.t1;Pocillopora_acuta_HIv2___RNAseq.g12376.t1;Pocillopora_acuta_HIv2___RNAseq.g12378.t1;Pocillopora_acuta_HIv2___RNAseq.g12745.t1;Pocillopora_acuta_HIv2___RNAseq.g12987.t1;Pocillopora_acuta_HIv2___RNAseq.g13818.t1;Pocillopora_acuta_HIv2___RNAseq.g13857.t1;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g14257.t1;Pocillopora_acuta_HIv2___RNAseq.g15163.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g19470.t1;Pocillopora_acuta_HIv2___RNAseq.g20144.t1;Pocillopora_acuta_HIv2___RNAseq.g20576.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g21518.t1;Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g22527.t1;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g25270.t1;Pocillopora_acuta_HIv2___RNAseq.g2565.t1;Pocillopora_acuta_HIv2___RNAseq.g26050.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g26590.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g27039.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28450.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g30027.t1;Pocillopora_acuta_HIv2___RNAseq.g30322.t1;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g30954.t1;Pocillopora_acuta_HIv2___RNAseq.g31347.t1;Pocillopora_acuta_HIv2___RNAseq.g4785.t1;Pocillopora_acuta_HIv2___RNAseq.g4791.t1;Pocillopora_acuta_HIv2___RNAseq.g4878.t1;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g8098.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8922.t1;Pocillopora_acuta_HIv2___RNAseq.g9084.t1;Pocillopora_acuta_HIv2___RNAseq.g9098.t1;Pocillopora_acuta_HIv2___RNAseq.g9118.t1;Pocillopora_acuta_HIv2___RNAseq.g9381.t1;Pocillopora_acuta_HIv2___RNAseq.g9756.t1;Pocillopora_acuta_HIv2___TS.g11111.t2;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g12453.t2;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g12860.t1;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g1359.t1;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g17199.t1;Pocillopora_acuta_HIv2___TS.g18100.t1;Pocillopora_acuta_HIv2___TS.g18104.t1;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g23133.t3;Pocillopora_acuta_HIv2___TS.g23144.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g23673.t1;Pocillopora_acuta_HIv2___TS.g5115.t2;Pocillopora_acuta_HIv2___TS.g5338.t1;Pocillopora_acuta_HIv2___TS.g5618.t1","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Hemicentin-1 (Fibulin-6) (FIBL-6);Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Nodal homolog (Nodal-related protein 1) (Xnr-1) (Xnr1) (nr-1);SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2);Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein);Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2];Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Tissue inhibitor of metalloproteinase;Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1) (TIMP-1);Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL);Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13);Bone morphogenetic protein 2 (BMP-2);Hemicentin-1 (Fibulin-6) (FIBL-6);NPC intracellular cholesterol transporter 2 (EPI-1) (Epididymal secretory protein E1) (Niemann Pick type C2 protein homolog);Noggin-2;Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Collagen triple helix repeat-containing protein 1;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Bactericidal permeability-increasing protein (BPI) (Lipopolysaccharide-binding protein) (LBP);Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amine oxidase copper domain-containing protein 1) (Histaminase);Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Tolloid-like protein 1 (EC 3.4.24.-) (Chicken tolloid-like protein 1) (Metalloprotease colloid);Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Chitin deacetylase 7 (BmCDA7) (EC 3.5.1.41);Secreted frizzled-related protein 5 (sFRP-5);Secreted frizzled-related protein 3 (sFRP-3) (Frizzled-related protein 1) (FrzB-1);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Tear acid lipase-like protein (TALLP);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Protein Wnt-8b;Protein Wnt-8a;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Trypsin-3 (EC 3.4.21.4) (Trypsin III);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Roundabout homolog 2;Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4);Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain];Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Probable oxidoreductase PXDNL (EC 1.-.-.-) (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1) (PRM1) (Vascular peroxidase 2);Equistatin (EI) (Cysteine proteinase inhibitor);Coagulation factor VIII (Procoagulant component);Coagulation factor VIII (Procoagulant component);Melanotransferrin (Membrane-bound transferrin-like protein p97) (CD antigen CD228);Roundabout homolog 2;Cathepsin L1 (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain];Hemicentin-1 (Fibulin-6) (FIBL-6);Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b (Complement C3b-alpha' chain); Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3b (Complement C3b-alpha' chain)];Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)];Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain];Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx);Methanethiol oxidase (MTO) (EC 1.8.3.4) (56 kDa selenium-binding protein) (SBP56) (SP56) (Selenium-binding protein 1);Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Matrilin-2;Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-1(VI) chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha chain;Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Hemicentin-1 (Fibulin-6) (FIBL-6);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha);Protein Wnt-8b;Protein Wnt-8b;Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Pregnancy zone protein (Alpha-2-macroglobulin) (Alpha-2-M) [Cleaved into: Alpha-2-macroglobulin 165 kDa subunit; Alpha-2-macroglobulin 35 kDa subunit];Complement C3 [Cleaved into: Complement C3 beta chain; Complement C3 alpha chain; C3a anaphylatoxin; Complement C3b (Complement C3b-alpha' chain)];Collagen alpha-1(XXVII) chain B;Signal peptide, CUB and EGF-like domain-containing protein 3;Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein)","Cluster 5: cellular anatomical structure"
"31","5",2.2,"GO:0071944","cell periphery","The broad region around and including the plasma membrane of a cell, encompassing the cell cortex (inside the cell), the plasma membrane, and any external encapsulating structures.","9.985% (274/2744)",0.001325775,2.88,"Pocillopora_acuta_HIv2___RNAseq.10010_t;Pocillopora_acuta_HIv2___RNAseq.18284_t;Pocillopora_acuta_HIv2___RNAseq.18788_t;Pocillopora_acuta_HIv2___RNAseq.25384_t;Pocillopora_acuta_HIv2___RNAseq.30415_t;Pocillopora_acuta_HIv2___RNAseq.6257_t;Pocillopora_acuta_HIv2___RNAseq.6942_t;Pocillopora_acuta_HIv2___RNAseq.7292_t;Pocillopora_acuta_HIv2___RNAseq.953_t;Pocillopora_acuta_HIv2___RNAseq.g10339.t1;Pocillopora_acuta_HIv2___RNAseq.g10475.t1;Pocillopora_acuta_HIv2___RNAseq.g10514.t1;Pocillopora_acuta_HIv2___RNAseq.g10927.t1;Pocillopora_acuta_HIv2___RNAseq.g10991.t1;Pocillopora_acuta_HIv2___RNAseq.g1102.t1;Pocillopora_acuta_HIv2___RNAseq.g11214.t1;Pocillopora_acuta_HIv2___RNAseq.g11345.t1;Pocillopora_acuta_HIv2___RNAseq.g11547.t1;Pocillopora_acuta_HIv2___RNAseq.g11548.t1;Pocillopora_acuta_HIv2___RNAseq.g11580.t1;Pocillopora_acuta_HIv2___RNAseq.g11747.t1;Pocillopora_acuta_HIv2___RNAseq.g11810.t1;Pocillopora_acuta_HIv2___RNAseq.g11916.t1;Pocillopora_acuta_HIv2___RNAseq.g1200.t1;Pocillopora_acuta_HIv2___RNAseq.g12115.t1;Pocillopora_acuta_HIv2___RNAseq.g1217.t1;Pocillopora_acuta_HIv2___RNAseq.g12223.t1;Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g12293.t1;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g12614.t2;Pocillopora_acuta_HIv2___RNAseq.g12619.t1;Pocillopora_acuta_HIv2___RNAseq.g12682.t1;Pocillopora_acuta_HIv2___RNAseq.g12752.t1;Pocillopora_acuta_HIv2___RNAseq.g12898.t1;Pocillopora_acuta_HIv2___RNAseq.g13044.t1;Pocillopora_acuta_HIv2___RNAseq.g13056.t1;Pocillopora_acuta_HIv2___RNAseq.g13060.t1;Pocillopora_acuta_HIv2___RNAseq.g13403.t1;Pocillopora_acuta_HIv2___RNAseq.g13533.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g13576.t1;Pocillopora_acuta_HIv2___RNAseq.g13716.t1;Pocillopora_acuta_HIv2___RNAseq.g13970.t2;Pocillopora_acuta_HIv2___RNAseq.g14013.t1a;Pocillopora_acuta_HIv2___RNAseq.g14348.t1;Pocillopora_acuta_HIv2___RNAseq.g14576.t1;Pocillopora_acuta_HIv2___RNAseq.g14869.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g15036.t2;Pocillopora_acuta_HIv2___RNAseq.g15097.t1;Pocillopora_acuta_HIv2___RNAseq.g15838.t1;Pocillopora_acuta_HIv2___RNAseq.g16.t1;Pocillopora_acuta_HIv2___RNAseq.g16050.t1;Pocillopora_acuta_HIv2___RNAseq.g16474.t1;Pocillopora_acuta_HIv2___RNAseq.g16699.t1;Pocillopora_acuta_HIv2___RNAseq.g16844.t1;Pocillopora_acuta_HIv2___RNAseq.g17085.t1;Pocillopora_acuta_HIv2___RNAseq.g17089.t1;Pocillopora_acuta_HIv2___RNAseq.g17090.t1;Pocillopora_acuta_HIv2___RNAseq.g17093.t1;Pocillopora_acuta_HIv2___RNAseq.g17117.t1;Pocillopora_acuta_HIv2___RNAseq.g1720.t1;Pocillopora_acuta_HIv2___RNAseq.g17495.t1;Pocillopora_acuta_HIv2___RNAseq.g17559.t1;Pocillopora_acuta_HIv2___RNAseq.g17622.t1;Pocillopora_acuta_HIv2___RNAseq.g17965.t1;Pocillopora_acuta_HIv2___RNAseq.g18059.t1;Pocillopora_acuta_HIv2___RNAseq.g18121.t1;Pocillopora_acuta_HIv2___RNAseq.g18123.t1;Pocillopora_acuta_HIv2___RNAseq.g1818.t1;Pocillopora_acuta_HIv2___RNAseq.g18273.t1;Pocillopora_acuta_HIv2___RNAseq.g1841.t1;Pocillopora_acuta_HIv2___RNAseq.g18501.t1;Pocillopora_acuta_HIv2___RNAseq.g18617.t1;Pocillopora_acuta_HIv2___RNAseq.g18951.t1;Pocillopora_acuta_HIv2___RNAseq.g18966.t1;Pocillopora_acuta_HIv2___RNAseq.g19042.t1;Pocillopora_acuta_HIv2___RNAseq.g19043.t1;Pocillopora_acuta_HIv2___RNAseq.g19152.t1;Pocillopora_acuta_HIv2___RNAseq.g19312.t1;Pocillopora_acuta_HIv2___RNAseq.g19392.t1;Pocillopora_acuta_HIv2___RNAseq.g19428.t1;Pocillopora_acuta_HIv2___RNAseq.g19452.t1;Pocillopora_acuta_HIv2___RNAseq.g1971.t1;Pocillopora_acuta_HIv2___RNAseq.g19855.t1;Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g20232.t1;Pocillopora_acuta_HIv2___RNAseq.g20413.t2;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g20831.t1;Pocillopora_acuta_HIv2___RNAseq.g20846.t1;Pocillopora_acuta_HIv2___RNAseq.g20860.t1;Pocillopora_acuta_HIv2___RNAseq.g21021.t1;Pocillopora_acuta_HIv2___RNAseq.g21169.t1;Pocillopora_acuta_HIv2___RNAseq.g21265.t1;Pocillopora_acuta_HIv2___RNAseq.g21476.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g21637.t1;Pocillopora_acuta_HIv2___RNAseq.g22283.t1;Pocillopora_acuta_HIv2___RNAseq.g22296.t1;Pocillopora_acuta_HIv2___RNAseq.g2263.t1b;Pocillopora_acuta_HIv2___RNAseq.g22644.t1;Pocillopora_acuta_HIv2___RNAseq.g2273.t1;Pocillopora_acuta_HIv2___RNAseq.g22964.t1;Pocillopora_acuta_HIv2___RNAseq.g23004.t1;Pocillopora_acuta_HIv2___RNAseq.g23181.t1;Pocillopora_acuta_HIv2___RNAseq.g23361.t1;Pocillopora_acuta_HIv2___RNAseq.g23414.t1;Pocillopora_acuta_HIv2___RNAseq.g23883.t2;Pocillopora_acuta_HIv2___RNAseq.g24029.t1;Pocillopora_acuta_HIv2___RNAseq.g24097.t1;Pocillopora_acuta_HIv2___RNAseq.g24120.t1;Pocillopora_acuta_HIv2___RNAseq.g24660.t1;Pocillopora_acuta_HIv2___RNAseq.g24675.t1;Pocillopora_acuta_HIv2___RNAseq.g24761.t1;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g25228.t1;Pocillopora_acuta_HIv2___RNAseq.g25317.t1;Pocillopora_acuta_HIv2___RNAseq.g25494.t1;Pocillopora_acuta_HIv2___RNAseq.g25689.t1;Pocillopora_acuta_HIv2___RNAseq.g25691.t1;Pocillopora_acuta_HIv2___RNAseq.g25867.t1;Pocillopora_acuta_HIv2___RNAseq.g25934.t1;Pocillopora_acuta_HIv2___RNAseq.g26058.t1;Pocillopora_acuta_HIv2___RNAseq.g26118.t1;Pocillopora_acuta_HIv2___RNAseq.g26272.t1;Pocillopora_acuta_HIv2___RNAseq.g26575.t1;Pocillopora_acuta_HIv2___RNAseq.g26586.t1;Pocillopora_acuta_HIv2___RNAseq.g26594.t2;Pocillopora_acuta_HIv2___RNAseq.g26596.t1;Pocillopora_acuta_HIv2___RNAseq.g26608.t1;Pocillopora_acuta_HIv2___RNAseq.g26672.t1;Pocillopora_acuta_HIv2___RNAseq.g26700.t1;Pocillopora_acuta_HIv2___RNAseq.g26783.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g27609.t1;Pocillopora_acuta_HIv2___RNAseq.g27978.t1;Pocillopora_acuta_HIv2___RNAseq.g28025.t1;Pocillopora_acuta_HIv2___RNAseq.g2813.t4;Pocillopora_acuta_HIv2___RNAseq.g28202.t1;Pocillopora_acuta_HIv2___RNAseq.g28213.t1;Pocillopora_acuta_HIv2___RNAseq.g28227.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g2827.t1;Pocillopora_acuta_HIv2___RNAseq.g28398.t1;Pocillopora_acuta_HIv2___RNAseq.g28466.t1;Pocillopora_acuta_HIv2___RNAseq.g28678.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g28815.t1;Pocillopora_acuta_HIv2___RNAseq.g28816.t1;Pocillopora_acuta_HIv2___RNAseq.g2915.t1;Pocillopora_acuta_HIv2___RNAseq.g29275.t1;Pocillopora_acuta_HIv2___RNAseq.g29506.t1;Pocillopora_acuta_HIv2___RNAseq.g29617.t1;Pocillopora_acuta_HIv2___RNAseq.g29670.t2;Pocillopora_acuta_HIv2___RNAseq.g29841.t1;Pocillopora_acuta_HIv2___RNAseq.g3016.t1;Pocillopora_acuta_HIv2___RNAseq.g30214.t1;Pocillopora_acuta_HIv2___RNAseq.g30398.t1;Pocillopora_acuta_HIv2___RNAseq.g30425.t2;Pocillopora_acuta_HIv2___RNAseq.g30723.t1;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___RNAseq.g30992.t1;Pocillopora_acuta_HIv2___RNAseq.g30994.t1a;Pocillopora_acuta_HIv2___RNAseq.g3166.t1;Pocillopora_acuta_HIv2___RNAseq.g344.t1;Pocillopora_acuta_HIv2___RNAseq.g3532.t1;Pocillopora_acuta_HIv2___RNAseq.g3723.t1;Pocillopora_acuta_HIv2___RNAseq.g3724.t1;Pocillopora_acuta_HIv2___RNAseq.g3743.t1;Pocillopora_acuta_HIv2___RNAseq.g3776.t1;Pocillopora_acuta_HIv2___RNAseq.g3854.t1;Pocillopora_acuta_HIv2___RNAseq.g4028.t1;Pocillopora_acuta_HIv2___RNAseq.g4031.t1c;Pocillopora_acuta_HIv2___RNAseq.g4213.t1;Pocillopora_acuta_HIv2___RNAseq.g4214.t1;Pocillopora_acuta_HIv2___RNAseq.g4369.t1;Pocillopora_acuta_HIv2___RNAseq.g4399.t2;Pocillopora_acuta_HIv2___RNAseq.g4757.t1;Pocillopora_acuta_HIv2___RNAseq.g4879.t1;Pocillopora_acuta_HIv2___RNAseq.g4919.t1;Pocillopora_acuta_HIv2___RNAseq.g5089.t1;Pocillopora_acuta_HIv2___RNAseq.g5252.t1;Pocillopora_acuta_HIv2___RNAseq.g5401.t1;Pocillopora_acuta_HIv2___RNAseq.g5755.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1;Pocillopora_acuta_HIv2___RNAseq.g6094.t2;Pocillopora_acuta_HIv2___RNAseq.g626.t1;Pocillopora_acuta_HIv2___RNAseq.g6366.t1;Pocillopora_acuta_HIv2___RNAseq.g6379.t1;Pocillopora_acuta_HIv2___RNAseq.g6468.t1;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g687.t1;Pocillopora_acuta_HIv2___RNAseq.g701.t1;Pocillopora_acuta_HIv2___RNAseq.g702.t1;Pocillopora_acuta_HIv2___RNAseq.g7100.t1;Pocillopora_acuta_HIv2___RNAseq.g7107.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___RNAseq.g7553.t1;Pocillopora_acuta_HIv2___RNAseq.g7625.t1;Pocillopora_acuta_HIv2___RNAseq.g7626.t1;Pocillopora_acuta_HIv2___RNAseq.g7627.t1;Pocillopora_acuta_HIv2___RNAseq.g7628.t1;Pocillopora_acuta_HIv2___RNAseq.g7660.t2;Pocillopora_acuta_HIv2___RNAseq.g7678.t1;Pocillopora_acuta_HIv2___RNAseq.g7692.t1;Pocillopora_acuta_HIv2___RNAseq.g8004.t1;Pocillopora_acuta_HIv2___RNAseq.g8276.t1;Pocillopora_acuta_HIv2___RNAseq.g8520.t1;Pocillopora_acuta_HIv2___RNAseq.g8890.t1;Pocillopora_acuta_HIv2___RNAseq.g8913.t1;Pocillopora_acuta_HIv2___RNAseq.g8915.t1;Pocillopora_acuta_HIv2___RNAseq.g898.t1b;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___RNAseq.g9466.t1;Pocillopora_acuta_HIv2___RNAseq.g9609.t1;Pocillopora_acuta_HIv2___RNAseq.g9723.t1;Pocillopora_acuta_HIv2___RNAseq.g9789.t1;Pocillopora_acuta_HIv2___RNAseq.g9811.t1;Pocillopora_acuta_HIv2___RNAseq.g9955.t1;Pocillopora_acuta_HIv2___TS.g10198.t2;Pocillopora_acuta_HIv2___TS.g1253.t1;Pocillopora_acuta_HIv2___TS.g1376.t2;Pocillopora_acuta_HIv2___TS.g14552.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g14962.t1;Pocillopora_acuta_HIv2___TS.g15134.t1;Pocillopora_acuta_HIv2___TS.g15668.t1;Pocillopora_acuta_HIv2___TS.g15672.t1;Pocillopora_acuta_HIv2___TS.g16172.t3;Pocillopora_acuta_HIv2___TS.g16482.t1;Pocillopora_acuta_HIv2___TS.g16484.t1;Pocillopora_acuta_HIv2___TS.g1731.t1;Pocillopora_acuta_HIv2___TS.g1768.t1;Pocillopora_acuta_HIv2___TS.g17699.t2;Pocillopora_acuta_HIv2___TS.g18947.t1;Pocillopora_acuta_HIv2___TS.g19097.t2;Pocillopora_acuta_HIv2___TS.g19790.t1;Pocillopora_acuta_HIv2___TS.g21128.t1;Pocillopora_acuta_HIv2___TS.g21857.t1;Pocillopora_acuta_HIv2___TS.g22105.t1;Pocillopora_acuta_HIv2___TS.g22622.t1;Pocillopora_acuta_HIv2___TS.g23115.t1;Pocillopora_acuta_HIv2___TS.g23175.t1;Pocillopora_acuta_HIv2___TS.g24662.t1;Pocillopora_acuta_HIv2___TS.g24807.t1;Pocillopora_acuta_HIv2___TS.g25792.t1c;Pocillopora_acuta_HIv2___TS.g26021.t1;Pocillopora_acuta_HIv2___TS.g27642.t1b;Pocillopora_acuta_HIv2___TS.g27807.t1;Pocillopora_acuta_HIv2___TS.g29407.t1;Pocillopora_acuta_HIv2___TS.g2952.t1;Pocillopora_acuta_HIv2___TS.g29618.t1;Pocillopora_acuta_HIv2___TS.g29621.t1;Pocillopora_acuta_HIv2___TS.g29848.t1;Pocillopora_acuta_HIv2___TS.g3024.t4;Pocillopora_acuta_HIv2___TS.g305.t1;Pocillopora_acuta_HIv2___TS.g3863.t1;Pocillopora_acuta_HIv2___TS.g4109.t3;Pocillopora_acuta_HIv2___TS.g4148.t1c;Pocillopora_acuta_HIv2___TS.g5171.t1;Pocillopora_acuta_HIv2___TS.g5415.t1;Pocillopora_acuta_HIv2___TS.g6578.t1;Pocillopora_acuta_HIv2___TS.g800.t1;Pocillopora_acuta_HIv2___TS.g8082.t1;Pocillopora_acuta_HIv2___TS.g8275.t1;Pocillopora_acuta_HIv2___TS.g9513.t1;Pocillopora_acuta_HIv2___TS.g9749.t1;Pocillopora_acuta_HIv2___TS.g9752.t3","Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor);Putative ammonium transporter 3;Metabotropic glutamate receptor 3 (mGluR3);Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);Synaptotagmin-10 (Synaptotagmin X) (SytX);Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2);Kinesin-like protein KIF17 (MmKIF17);Glycine betaine/proline/choline/ectoine transporter VP1456;Adenosine receptor A2b;Myoferlin (Fer-1-like protein 3);DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1);Trimethylamine transporter (TMA transporter) (TMA-specific transporter);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor);Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I);Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Hemicentin-1 (Fibulin-6) (FIBL-6);Tetraspanin-33 (Tspan-33);Spectrin beta chain, erythrocytic (Beta-I spectrin);Neuronal acetylcholine receptor subunit alpha-10 (Alpha 10 nAChR) (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Phospholipid phosphatase 3 (EC 3.1.3.-) (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP);Adenosine receptor A2a;Ras-related protein Rab-3;Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho);Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110);Universal stress protein A-like protein;Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c);A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-);Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4);Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Deleted in malignant brain tumors 1 protein) (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein);Dopamine receptor 4;Low-density lipoprotein receptor-related protein 6 (LRP-6);Synaptotagmin-9 (Synaptotagmin IX) (SytIX);Protein sidekick-2;Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP);Tyrosine-protein kinase receptor torso (EC 2.7.10.1);Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein);Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) (x-BETA1AR);Collagen alpha-4(VI) chain;G-protein coupled receptor GRL101;Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Collagen alpha-1(XXIV) chain;Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8);Laminin subunit gamma-1;Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor);Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase) (Protein kinase RCK);Solute carrier family 12 member 2 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (NKCC1) (Na-K-CL symporter);Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain];Kelch-like protein 5;Peroxidasin homolog pxn-2 (EC 1.11.2.-);Peroxidasin homolog pxn-2 (EC 1.11.2.-);Peroxidasin homolog pxn-2 (EC 1.11.2.-);GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1);Nitric oxide synthase 1 (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Nitric oxide synthase, brain) (bNOS) (Peptidyl-cysteine S-nitrosylase NOS1);Transmembrane protein 117;Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4);TWiK family of potassium channels protein 7;Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln));Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor);Aquaporin AQPAe.a;Sodium/calcium exchanger NCL2 (Na(+)/Ca(2+)-exchange protein NCL2) (OsEFCAX2) (Protein NCX-like 2) (OsNCL2);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3);Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3);Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2);Putative potassium channel protein YugO;Tetraspanin-33 (Tspan-33);Potassium voltage-gated channel subfamily A member 2 (RAK) (RBK2) (RCK5) (Voltage-gated potassium channel subunit Kv1.2);Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G);Anoctamin-7 (New gene expressed in prostate homolog) (Transmembrane protein 16G);High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter);Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13);1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2);Endothelin-converting enzyme homolog (ECE) (EC 3.4.24.-);Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2);Cortactin-binding protein 2 (CortBP2);Glycine betaine transporter 1;Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1);Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Solute carrier family 53 member 1 (Phosphate exporter SLC53A1) (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor) (Xenotropic and polytropic retrovirus receptor 1);Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86);Hemagglutinin/amebocyte aggregation factor (18K-LAF);Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein homolog) (Protein primglo) (xPgo);Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2);Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Reversion-inducing cysteine-rich protein with Kazal motifs;CD63 antigen (CD antigen CD63);BTB/POZ domain-containing protein KCTD16;Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71);Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1);Putative ammonium transporter 1;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)];Rho GTPase-activating protein 32 (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS);Myosin-VIIa (Protein crinkled);Fibroblast growth factor receptor (SpFGFR) (EC 2.7.10.1);5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B);VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1);Epithelial sodium channel subunit alpha (Alpha-ENaC) (Epithelial Na(+) channel subunit alpha) (Alpha-NaCH) (Amiloride-sensitive sodium channel subunit alpha) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA);Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];E3 ubiquitin-protein ligase RNF167 (EC 2.3.2.27) (RING finger protein 167);Cholesterol uptake protein 1;Annexin A6 (Annexin VI) (Annexin-6);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)];Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a);TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3);Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor);Ras-GEF domain-containing family member 1B;Arrestin domain-containing protein 3;Fibrillin-1 [Cleaved into: Asprosin];Rhodopsin, GQ-coupled (GQ-rhodopsin);Voltage-dependent calcium channel type A subunit alpha-1 (Cacophony protein);(3R)-3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (Estradiol 17-beta-dehydrogenase 8) (EC 1.1.1.62) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239);Neogenin;Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9);Monocarboxylate transporter 3 (MCT 3) (Retinal epithelial membrane protein) (Solute carrier family 16 member 8);Hemicentin-2;Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1);Neuronal acetylcholine receptor subunit alpha-7 (nAChR7) (Nicotinic acetylcholine receptor subunit alpha-7);Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3);Protein mesh;Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE);Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4);Cubilin (Intrinsic factor-cobalamin receptor);EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46) (EC 3.6.5.2);Neuronal acetylcholine receptor subunit beta-3;QRFP-like peptide receptor;Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein);Ephrin-B2a;Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Synaptotagmin-1 (Synaptotagmin I) (SytI);Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) (ZnT-8);Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2);Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2);Protein YIPF4 (YIP1 family member 4);Septin-2;Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3);Matrilin-2;Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I);Storkhead-box protein 1;Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155);Rootletin (Ciliary rootlet coiled-coil protein);InaD-like protein (Inadl protein) (Channel-interacting PDZ domain-containing protein) (Pals1-associated tight junction protein) (Protein associated to tight junctions);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (Yolk sac permease-like molecule 3);Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2);Rhodopsin;Protein PLANT CADMIUM RESISTANCE 2 (AtPCR2);Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9);Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)];Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP);Protein sprouty homolog 2 (Spry-2);Fibroblast growth factor receptor (HrFGFR) (EC 2.7.10.1);Tachykinin-like peptides receptor 86C (NKD);Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII);Synaptotagmin-1 (Synaptotagmin I) (SytI);Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2);Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2);Engulfment and cell motility protein 1 (Protein ced-12 homolog);Serotransferrin;Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD);Calcium/calmodulin-dependent protein kinase type II alpha chain (CaM-kinase II alpha chain) (EC 2.7.11.17);Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta);Short transient receptor potential channel 5 (TrpC5) (Capacitative calcium entry channel 2) (CCE2) (Transient receptor protein 5) (TRP-5) (mTRP5) (Trp-related protein 5);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo);Serine/threonine-protein kinase PAK mbt (EC 2.7.11.1) (Protein mushroom bodies tiny) (p21-activated kinase-related protein);Adhesion G protein-coupled receptor L4;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)];Adenosine receptor A2a;Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase);Polycystin-2 (Polycystic kidney disease 2 protein homolog);Sperm receptor for egg jelly (suREJ);Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2);Insulin-like growth factor-binding protein complex acid labile subunit (ALS);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form];Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281);Toll-like receptor Tollo (Toll-like receptor 8);Toll-like receptor 2 (CD antigen CD282);Toll-like receptor 6 (CD antigen CD286);Diacylglycerol lipase-beta (DAGL-beta) (DAGLbeta) (DGL-beta) (EC 3.1.1.116) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta);Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2);Netrin-1;Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein);Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1);Hemicentin-1 (Fibulin-6) (FIBL-6);Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor);Monocarboxylate transporter 8 (MCT 8) (Solute carrier family 16 member 2);ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase);DIS3-like exonuclease 1 (EC 3.1.13.1);Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor);Protein dispatched;Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q);Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (MAR1);Sugar transporter SWEET1;Cadherin-23 (Otocadherin);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (Diglyceride kinase beta) (DGK-beta);Mechanosensory protein 2;Myeloid differentiation primary response protein MyD88;Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7);Sodium channel protein 1 brain (Sodium channel protein I brain);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Sodium- and chloride-dependent GABA transporter 3) (GAT-3) (Solute carrier family 6 member 13);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Leucine-rich repeat-containing G-protein coupled receptor 6;Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Neurexin-4 (Neurexin IV);Chloride intracellular channel protein 3 (Glutaredoxin-like oxidoreductase CLIC3) (EC 1.8.-.-);Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b);Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3);Major facilitator superfamily domain-containing protein 12;Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA);Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Hemicentin-1 (Fibulin-6) (FIBL-6);Neuronal cell adhesion molecule (Nr-CAM) (Ankyrin-binding cell adhesion molecule NrCAM) (Neuronal surface protein Bravo) (rBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related);Hemicentin-1 (Fibulin-6) (FIBL-6);Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1);Putative potassium channel protein YugO;Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1];Glucosylceramide transporter ABCA12 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12) (ATP-binding cassette 12);Matrilin-2;Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)];Low-density lipoprotein receptor-related protein 6 (LRP-6);Low-density lipoprotein receptor-related protein 6 (LRP-6);Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (Neutrophil NADPH oxidase factor 2) (p67-phox);Protein unc-13 homolog C (Munc13-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5);Pejvakin (Autosomal recessive deafness type 59 protein);Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM);Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2);C-type lectin domain family 1 member B (C-type lectin-like receptor 2) (CLEC-2);Protocadherin-like protein;Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C);Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1);Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI);Carcinine transporter;Fibropellin-1 (Epidermal growth factor-related protein 1) (Fibropellin-I) (SpEGF I) (UEGF-1);Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]","6.523% (179/2744)",0.2837933,0.55,NA,NA,"Cluster 5: cellular anatomical structure"
"32","5",5.02,"GO:0005938","cell cortex","The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.","8.482% (19/224)",0.5998236,0.22,NA,NA,"8.482% (19/224)",0.0004742814,3.32,"Pocillopora_acuta_HIv2___RNAseq.2533_t;Pocillopora_acuta_HIv2___RNAseq.820_t;Pocillopora_acuta_HIv2___RNAseq.g14253.t1;Pocillopora_acuta_HIv2___RNAseq.g16665.t1;Pocillopora_acuta_HIv2___RNAseq.g23178.t1;Pocillopora_acuta_HIv2___RNAseq.g23210.t1;Pocillopora_acuta_HIv2___RNAseq.g26331.t1;Pocillopora_acuta_HIv2___RNAseq.g27031.t1;Pocillopora_acuta_HIv2___RNAseq.g5388.t1;Pocillopora_acuta_HIv2___RNAseq.g7219.t1;Pocillopora_acuta_HIv2___RNAseq.g7635.t1;Pocillopora_acuta_HIv2___RNAseq.g8148.t1;Pocillopora_acuta_HIv2___RNAseq.g9554.t1;Pocillopora_acuta_HIv2___TS.g14217.t2;Pocillopora_acuta_HIv2___TS.g15590.t1;Pocillopora_acuta_HIv2___TS.g24743.t1;Pocillopora_acuta_HIv2___TS.g6576.t2;Pocillopora_acuta_HIv2___TS.g7543.t1;Pocillopora_acuta_HIv2___TS.g8258.t1","Hemicentin-1 (Fibulin-6) (FIBL-6);Maternal embryonic leucine zipper kinase (MELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase);Hemicentin-1 (Fibulin-6) (FIBL-6);Cortactin-binding protein 2 (CortBP2);Hemicentin-2;Hemicentin-2;Septin-2;Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2);Hemicentin-1 (Fibulin-6) (FIBL-6);Cortactin-binding protein 2 (CortBP2);Small cysteine-rich protein 1 (Amil-SCRiP1) (SCRiP1);Hemicentin-1 (Fibulin-6) (FIBL-6);CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein);TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6);Hemicentin-1 (Fibulin-6) (FIBL-6);Hemicentin-2;LIM domain-containing protein jub;SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains);Hemicentin-2","Cluster 5: cellular anatomical structure"
"33","5",4.82,"GO:0009986","cell surface","The external part of the cell wall and/or plasma membrane.","12.203% (36/295)",0.003376914,2.47,"Pocillopora_acuta_HIv2___RNAseq.g12287.t1;Pocillopora_acuta_HIv2___RNAseq.g12289.t1;Pocillopora_acuta_HIv2___RNAseq.g12293.t1;Pocillopora_acuta_HIv2___RNAseq.g12410.t1;Pocillopora_acuta_HIv2___RNAseq.g12682.t1;Pocillopora_acuta_HIv2___RNAseq.g13552.t1;Pocillopora_acuta_HIv2___RNAseq.g14640.t1;Pocillopora_acuta_HIv2___RNAseq.g14871.t1;Pocillopora_acuta_HIv2___RNAseq.g18123.t1;Pocillopora_acuta_HIv2___RNAseq.g18767.t1;Pocillopora_acuta_HIv2___RNAseq.g20413.t2;Pocillopora_acuta_HIv2___RNAseq.g20688.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g22283.t1;Pocillopora_acuta_HIv2___RNAseq.g2263.t1b;Pocillopora_acuta_HIv2___RNAseq.g24120.t1;Pocillopora_acuta_HIv2___RNAseq.g26575.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___RNAseq.g28251.t1;Pocillopora_acuta_HIv2___RNAseq.g28741.t1;Pocillopora_acuta_HIv2___RNAseq.g3724.t1;Pocillopora_acuta_HIv2___RNAseq.g4369.t1;Pocillopora_acuta_HIv2___RNAseq.g4399.t2;Pocillopora_acuta_HIv2___RNAseq.g6836.t1;Pocillopora_acuta_HIv2___RNAseq.g7241.t1;Pocillopora_acuta_HIv2___RNAseq.g7243.t1;Pocillopora_acuta_HIv2___RNAseq.g7248.t1;Pocillopora_acuta_HIv2___RNAseq.g9334.t1;Pocillopora_acuta_HIv2___TS.g1768.t1;Pocillopora_acuta_HIv2___TS.g25792.t1c;Pocillopora_acuta_HIv2___TS.g27642.t1b;Pocillopora_acuta_HIv2___TS.g29618.t1;Pocillopora_acuta_HIv2___TS.g29621.t1;Pocillopora_acuta_HIv2___TS.g5415.t1;Pocillopora_acuta_HIv2___TS.g800.t1;Pocillopora_acuta_HIv2___TS.g9777.t1","Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho);Excitatory amino acid transporter 2 (GLT-1) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2);Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c);Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4);Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein);Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);CD63 antigen (CD antigen CD63);Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71);Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Neogenin;Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit);Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Tyrosine-protein phosphatase Lar (EC 3.1.3.48) (Protein-tyrosine-phosphate phosphohydrolase) (dLAR);Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1);Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1];Low-density lipoprotein receptor-related protein 6 (LRP-6);Low-density lipoprotein receptor-related protein 6 (LRP-6);C-type lectin domain family 1 member B (C-type lectin-like receptor 2) (CLEC-2);Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C);Oncoprotein-induced transcript 3 protein","9.492% (28/295)",2.699179e-06,5.57,"Pocillopora_acuta_HIv2___RNAseq.10263_t;Pocillopora_acuta_HIv2___RNAseq.26508_t;Pocillopora_acuta_HIv2___RNAseq.g10378.t1;Pocillopora_acuta_HIv2___RNAseq.g1127.t2;Pocillopora_acuta_HIv2___RNAseq.g1273.t1;Pocillopora_acuta_HIv2___RNAseq.g18125.t1;Pocillopora_acuta_HIv2___RNAseq.g18763.t1;Pocillopora_acuta_HIv2___RNAseq.g20876.t1;Pocillopora_acuta_HIv2___RNAseq.g24688.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g27047.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28252.t1;Pocillopora_acuta_HIv2___RNAseq.g29143.t2;Pocillopora_acuta_HIv2___RNAseq.g5181.t1;Pocillopora_acuta_HIv2___RNAseq.g562.t1;Pocillopora_acuta_HIv2___RNAseq.g565.t1;Pocillopora_acuta_HIv2___RNAseq.g682.t1;Pocillopora_acuta_HIv2___RNAseq.g8670.t1;Pocillopora_acuta_HIv2___RNAseq.g8821.t1;Pocillopora_acuta_HIv2___RNAseq.g8914.t1;Pocillopora_acuta_HIv2___RNAseq.g8916.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g14528.t1a;Pocillopora_acuta_HIv2___TS.g18622.t1b;Pocillopora_acuta_HIv2___TS.g23673.t1","Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form];Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You);Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206);Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein);von Willebrand factor D and EGF domain-containing protein;Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S);Melanotransferrin (Membrane-bound transferrin-like protein p97) (MTf) (CD antigen CD228);Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha);Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Protein Wnt-7a;Protein Wnt-8a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1);Roundabout homolog 2;Roundabout homolog 2;Frizzled-5 (Fz-5);Frizzled-5 (Fz-5) (hFz5) (FzE5);Roundabout homolog 1;Riboflavin-binding protein (RBP) [Cleaved into: Riboflavin-binding protein, plasma form; Riboflavin-binding protein, yolk major form; Riboflavin-binding protein, yolk minor form];Complement C3 [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc) (Neutrophil chemotactic factor-2) (ENCF-2); Complement C3 alpha chain; C3a anaphylatoxin (Neutrophil chemotactic factor-1) (ENCF-1); Acylation stimulating protein (ASP) (C3adesArg); Complement C3b (Complement C3b-alpha' chain); Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2];Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment];Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)];Signal peptide, CUB and EGF-like domain-containing protein 3","Cluster 5: cellular anatomical structure"
"34","5",4.59,"GO:0045177","apical part of cell","The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue.","7.453% (24/322)",0.5830232,0.23,NA,NA,"6.832% (22/322)",0.003057013,2.51,"Pocillopora_acuta_HIv2___RNAseq.g11497.t1;Pocillopora_acuta_HIv2___RNAseq.g16285.t1;Pocillopora_acuta_HIv2___RNAseq.g16484.t1;Pocillopora_acuta_HIv2___RNAseq.g16928.t3;Pocillopora_acuta_HIv2___RNAseq.g17517.t1;Pocillopora_acuta_HIv2___RNAseq.g17519.t1;Pocillopora_acuta_HIv2___RNAseq.g23588.t1;Pocillopora_acuta_HIv2___RNAseq.g26270.t1a;Pocillopora_acuta_HIv2___RNAseq.g26979.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g28971.t1a;Pocillopora_acuta_HIv2___RNAseq.g30726.t1;Pocillopora_acuta_HIv2___RNAseq.g5342.t1;Pocillopora_acuta_HIv2___RNAseq.g7895.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g12304.t1;Pocillopora_acuta_HIv2___TS.g23602.t1;Pocillopora_acuta_HIv2___TS.g30706.t1;Pocillopora_acuta_HIv2___TS.g4840.t1;Pocillopora_acuta_HIv2___TS.g5308.t2;Pocillopora_acuta_HIv2___TS.g6576.t2;Pocillopora_acuta_HIv2___TS.g7543.t1","Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Regulator of G-protein signaling 19 (RGS19) (G-alpha-interacting protein) (GAIP);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin);Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1);Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form];Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5);Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339);Protein jagged-1 (Jagged1) (CD antigen CD339);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69);Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J);Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito];Proton-coupled folate transporter (Solute carrier family 46 member 1);Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14);LIM domain-containing protein jub;SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains)","Cluster 5: cellular anatomical structure"
"35","6",8.19,"GO:0034706","sodium channel complex","An ion channel complex through which sodium ions pass.","36.364% (4/11)",0.007230172,2.14,"Pocillopora_acuta_HIv2___RNAseq.g24029.t1;Pocillopora_acuta_HIv2___TS.g14960.t2;Pocillopora_acuta_HIv2___TS.g16172.t3;Pocillopora_acuta_HIv2___TS.g21128.t1","Epithelial sodium channel subunit alpha (Alpha-ENaC) (Epithelial Na(+) channel subunit alpha) (Alpha-NaCH) (Amiloride-sensitive sodium channel subunit alpha) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA);Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6);Sodium channel protein 1 brain (Sodium channel protein I brain);Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b)","0% (0/11)",1,0,NA,NA,"Cluster 6: protein-containing complex"
"36","6",7.7,"GO:1902710","GABA receptor complex",NA,"45.455% (5/11)",0.0008056184,3.09,"Pocillopora_acuta_HIv2___RNAseq.g19870.t1;Pocillopora_acuta_HIv2___RNAseq.g21572.t1a;Pocillopora_acuta_HIv2___RNAseq.g2519.t1;Pocillopora_acuta_HIv2___RNAseq.g27413.t1;Pocillopora_acuta_HIv2___TS.g305.t1","Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20);Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3);Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20)","0% (0/11)",1,0,NA,NA,"Cluster 6: protein-containing complex"
"37","6",6.34,"GO:0005581","collagen trimer","A protein complex consisting of three collagen chains assembled into a left-handed triple helix. These trimers typically assemble into higher order structures.","7.937% (5/63)",0.5328053,0.27,NA,NA,"26.984% (17/63)",1.116414e-05,4.95,"Pocillopora_acuta_HIv2___RNAseq.g1119.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g14375.t1;Pocillopora_acuta_HIv2___RNAseq.g17508.t1b;Pocillopora_acuta_HIv2___RNAseq.g22638.t1;Pocillopora_acuta_HIv2___RNAseq.g25761.t1;Pocillopora_acuta_HIv2___RNAseq.g26200.t1;Pocillopora_acuta_HIv2___RNAseq.g28794.t1;Pocillopora_acuta_HIv2___RNAseq.g28803.t1b;Pocillopora_acuta_HIv2___TS.g12846.t1;Pocillopora_acuta_HIv2___TS.g12860.t1;Pocillopora_acuta_HIv2___TS.g1340.t1b;Pocillopora_acuta_HIv2___TS.g1350.t1;Pocillopora_acuta_HIv2___TS.g1359.t1;Pocillopora_acuta_HIv2___TS.g15832.t1;Pocillopora_acuta_HIv2___TS.g23178.t1;Pocillopora_acuta_HIv2___TS.g24066.t1","Collagen alpha-6(VI) chain;Collagen alpha-4(VI) chain;Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Collagen triple helix repeat-containing protein 1;Collagen alpha-1(IV) chain (Collagen type IV alpha 1);Collagen alpha-6(VI) chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen homolog];Collagen alpha-1(VI) chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha chain;Collagen alpha-2(I) chain (Alpha-2 type I collagen);Collagen alpha-1(XXVII) chain B;Collagen alpha-2(IV) chain","Cluster 6: protein-containing complex"
"38","6",7.46,"GO:0005589","collagen type VI trimer","A collagen heterotrimer containing type VI alpha chains in alpha1(VI)alpha2(VI)alpha3(VI) trimers; type VI collagen triple helices associate to form beaded fibrils.","8.696% (2/23)",0.5338913,0.27,NA,NA,"17.391% (4/23)",0.008574668,2.07,"Pocillopora_acuta_HIv2___RNAseq.g1119.t1;Pocillopora_acuta_HIv2___RNAseq.g14347.t1;Pocillopora_acuta_HIv2___RNAseq.g14375.t1;Pocillopora_acuta_HIv2___RNAseq.g25761.t1","Collagen alpha-6(VI) chain;Collagen alpha-4(VI) chain;Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain);Collagen alpha-6(VI) chain","Cluster 6: protein-containing complex"
"39","7",8.03,"GO:0014731","spectrin-associated cytoskeleton","The part of the cytoskeleton composed of spectrin, protein 4.1 and ankyrin. Spectrin-associated cytoskeleton is associated with the plasma membrane.","38.462% (5/13)",0.001972381,2.71,"Pocillopora_acuta_HIv2___RNAseq.g11810.t1;Pocillopora_acuta_HIv2___RNAseq.g20766.t1;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___RNAseq.g5859.t1;Pocillopora_acuta_HIv2___TS.g18947.t1","Spectrin beta chain, erythrocytic (Beta-I spectrin);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)","0% (0/13)",1,0,NA,NA,"Cluster 7: intracellular organelle"
"40","7",8.8,"GO:0008091","spectrin","Membrane associated dimeric protein (240 and 220 kDa) of erythrocytes. Forms a complex with ankyrin, actin and probably other components of the membrane cytoskeleton, so that there is a mesh of proteins underlying the plasma membrane, potentially restricting the lateral mobility of integral proteins.","50% (3/6)",0.007463283,2.13,"Pocillopora_acuta_HIv2___RNAseq.g11810.t1;Pocillopora_acuta_HIv2___RNAseq.g30836.t1;Pocillopora_acuta_HIv2___TS.g18947.t1","Spectrin beta chain, erythrocytic (Beta-I spectrin);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41);Spectrin beta chain, non-erythrocytic 2 (Beta SpIII sigma 1) (Beta-III spectrin) (Glutamate transporter EAAT4-associated protein 41) (SPNB-3) (Spectrin-like protein GTRAP41)","0% (0/6)",1,0,NA,NA,"Cluster 7: intracellular organelle"
"41","7",8.8,"GO:0033093","Weibel-Palade body","A large, elongated, rod-shaped secretory granule characteristic of vascular endothelial cells that contain a number of structurally and functionally distinct proteins, of which the best characterized are von Willebrand factor (VWF) and P-selectin. Weibel-Palade bodies are formed from the trans-Golgi network in a process that depends on VWF, which is densely packed in a highly organized manner, and on coat proteins that remain associated with the granules. Upon cell stimulation, regulated exocytosis releases the contained proteins to the cell surface, where they act in the recruitment of platelets and leukocytes and in inflammatory and vasoactive responses.","50% (3/6)",0.007463283,2.13,"Pocillopora_acuta_HIv2___RNAseq.g2263.t1b;Pocillopora_acuta_HIv2___RNAseq.g2813.t4;Pocillopora_acuta_HIv2___RNAseq.g584.t3a","Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71);EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46) (EC 3.6.5.2);von Willebrand factor (vWF)","0% (0/6)",1,0,NA,NA,"Cluster 7: intracellular organelle"
"42","7",7.1,"GO:0005796","Golgi lumen","The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.","3.03% (1/33)",0.9277823,0.03,NA,NA,"24.242% (8/33)",1.675537e-05,4.78,"Pocillopora_acuta_HIv2___RNAseq.21015_t;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g17416.t1;Pocillopora_acuta_HIv2___RNAseq.g24896.t1;Pocillopora_acuta_HIv2___RNAseq.g28196.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g18622.t1b","Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain];Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Glypican-5 [Cleaved into: Secreted glypican-5];Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP);Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)]","Cluster 7: intracellular organelle"
"43","7",5.81,"GO:0005788","endoplasmic reticulum lumen","The volume enclosed by the membranes of the endoplasmic reticulum.","3.361% (4/119)",0.9837918,0.01,NA,NA,"10.084% (12/119)",0.001194642,2.92,"Pocillopora_acuta_HIv2___RNAseq.g13818.t1;Pocillopora_acuta_HIv2___RNAseq.g15290.t1;Pocillopora_acuta_HIv2___RNAseq.g21477.t1;Pocillopora_acuta_HIv2___RNAseq.g21479.t1;Pocillopora_acuta_HIv2___RNAseq.g21481.t1;Pocillopora_acuta_HIv2___RNAseq.g21967.t1;Pocillopora_acuta_HIv2___RNAseq.g23886.t1;Pocillopora_acuta_HIv2___RNAseq.g27038.t1;Pocillopora_acuta_HIv2___RNAseq.g28226.t2;Pocillopora_acuta_HIv2___RNAseq.g673.t1;Pocillopora_acuta_HIv2___TS.g11002.t4;Pocillopora_acuta_HIv2___TS.g30131.t1","Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13);Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain];Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C);Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)];Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta);Protein Wnt-7a;Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2);Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein];Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)","Cluster 7: intracellular organelle"
